Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Financial Performance and Strategy news
(page 18)
4 November 2025
BP Q3 2025 Financial Results
Q3 saw $7.8bn cash flow, $2.2bn RC profit. Upstream reliability at 96.8%, refining at 96.6%. $4bn+ divestments expected, $14.5bn capex on track. Net debt stable at $26.1bn.
4 November 2025
Aramco Q3 2025 Financial Results
Adjusted net income rose to $28B. Cash flow and free cash flow increased. Gearing ratio improved. Dividends declared. Investments in HUMAIN and Fujian reflect strategic growth.
3 November 2025
Ørsted Divests 50% of Hornsea 3 to Apollo
Ørsted sells 50% of Hornsea 3 to Apollo, enhancing capital structure. The deal, worth approx. DKK 39 billion, is set to close by year-end, pending regulatory approval.
3 November 2025
Eastman Q3 2025 Financial Results
Strong cash flow, inventory reduction, cost-cutting, and shareholder returns amid weak demand. Focus on cash, cost, and circular economy for future growth.
3 November 2025
Evonik Sells Betaines Business in Indonesia
Evonik divests its Bekasi site to focus on sustainable specialties, continuing its strategic shift from global betaine operations.
3 November 2025
SABIC Reports 45% Rise in Q3 2025 Net Income
Q3 revenues hit SAR 34.3B; free cash flow up 81%. MTBE project launched early. 90+ new products introduced. Local content increased by 17%.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
3 November 2025
bp Sells Non-Controlling US Midstream Interests for $1.5 Billion
bp retains control of strategic assets, advancing its $20B divestment goal by 2027. Transaction involves phased payments and regulatory approvals.
31 October 2025
LyondellBasell Q3 2025 Earnings Report
Reported net loss of $890M, EBITDA of $(480)M. Cash from operations at $983M. Continued focus on operational improvements, asset sales, and cash management.
31 October 2025
Linde Q3 2025 Financial Results
Linde reports Q3 2025 results, highlighting its role in industrial gases and engineering across diverse markets, supporting sustainability and energy transition efforts.
31 October 2025
KMG Eurobonds Begin Trading on AIX
KMG debuts in the yuan market with Dim Sum bonds on AIX, diversifying funding and expanding its investor base. The issuance attracted high investor interest and positive analyst reviews.
31 October 2025
Kulzer, a Mitsui Chemicals Subsidiary, Targets EMEA and Americas
Kulzer restructures to enhance efficiency, consolidates production in Germany, and leverages digital transformation to boost sales and competitiveness in priority markets.
31 October 2025
Fuchs SE: Q3 Earnings Stable
Sales rose 1% to EUR 2,700 million in nine months. EBIT fell 2% due to market challenges. Q3 earnings improved over Q2 and last year's peak. Outlook from July confirmed.
30 October 2025
Aptar Q3 2025 Financial Results
Sales up 6%, net income up 28%. Strong growth in Pharma and Closures. Adjusted EBITDA margin rose to 23.2%. $70M returned to shareholders.
30 October 2025
Lilly Q3 2025 Financials: Revenue Up 54%, R&D Progress, Guidance Raised
Revenue growth driven by incretin demand. Advanced orforglipron trials, FDA approval for Inluriyo. Expanded manufacturing in Virginia, Texas, Puerto Rico.
30 October 2025
Aptar Q3 2025 Financial Results
Sales up 6%, net income up 28%, EPS up 30%. Strong growth in Pharma and Closures. $70M returned to shareholders.
30 October 2025
Repsol Reports €1.177 Billion Net Income Through September
Adjusted income reached €2.173B, driven by improved Q3 results. Despite lower crude prices, net income doubled in Q3. Dividend to exceed €1/share by 2026.
30 October 2025
Merck Announces Q3 2025 Financial Results
Sales rose 4% to $17.3B. KEYTRUDA up 10%, GARDASIL down 24%. GAAP EPS $2.32, Non-GAAP $2.58. FDA approved KEYTRUDA QLEX. Acquired Verona Pharma. Full-year sales outlook: $64.5B-$65B.
30 October 2025
dsm-firmenich Q3 2025 Update
Solid growth in Q3 with 2% organic sales increase. Updated 2025 outlook: €2.3B Adjusted EBITDA. ANH exit ongoing. Share buyback 85% complete.
30 October 2025
Statkraft Sells Assets for NOK 13.5 Billion in Q3 2025
Statkraft's Q3 results fell due to low prices and negative hedging. Asset sales aim to reduce complexity and fund growth in prioritized markets and technologies.
30 October 2025
Technip Energies 9M 2025 Results
Revenue and EBITDA up 9% Y/Y. Acquired Ecovyst's AM&C business. Major LNG contract in the US. Strong outlook in LNG, decarbonization, and sustainable fuels.
30 October 2025
WACKER Q3 Results Align with Expectations, Adjusts Full-Year Forecast
Q3 sales fell 6% to €1.34B, EBITDA dropped 23% to €112M. Net result was €-82M. Focus on cash and costs. Full-year EBITDA in lower expected range.
30 October 2025
Covestro Q3 2025: Results Meet Expectations, Effective Cost-Cutting
Despite challenges, cost-cutting and strategic investments drive progress. Full-year forecast narrowed; focus on sustainable growth and innovation continues.
30 October 2025
Clariant Boosts Q3 2025 EBITDA Margin to 17.9% Amid Market Challenges
Q3 sales fell 3% in local currencies. Performance programs and cost management improved EBITDA margin. 2025 outlook: sales growth at 1-3%, EBITDA margin 17-18%.
29 October 2025
Air Liquide Issues €2.15 Billion Bond for DIG Airgas Acquisition
The bond, oversubscribed and rated "A", funds a strategic acquisition in South Korea, enhancing market presence in key sectors with maturities up to 12 years at under 3% interest.
29 October 2025
Iberdrola Launches €1 Billion EU Green Hybrid Bond
Iberdrola's €1 billion green hybrid bond saw high demand, oversubscribed 8 times, with a 3.75% coupon. It aligns with EU Green Bond Standard, attracting sustainable investors.
29 October 2025
UPM Q3 2025: Resilient Performance Amid Weak Markets
Sales and EBIT declined. Strategic reviews and partnerships initiated. Plywood and paper production adjustments. Biorefinery progress. Sustainability recognized. Uncertainty persists.
29 October 2025
Equinor Q3 2025 Financial Results
Adjusted operating income at $6.21B. Production up 7%. Strong cash flow, cost focus, and strategic developments. Dividend set at $0.37/share.
29 October 2025
OMV Boosts Q3 2025 Clean CCS Operating Result by 20% to EUR 1.3 Billion
Fuels and Chemicals drive growth; Energy segment declines. Cash flow up 7%, leverage at 16%. Progress on Borouge Group and Neptun Deep project.
29 October 2025
Neste Q3 2025 Interim Report
Improved Q3 results driven by performance actions and market recovery. Renewable and oil product sales rose, but cash flow was negative. Strategic growth in Rotterdam continues.
29 October 2025
BASF Q3 2025 Earnings Slightly Exceed Market Expectations
Sales fell 3% due to currency effects and lower prices. EBITDA before special items was €1.5 billion. Share buyback program to start in November 2025.
← Previous
Next →
